mental health trends

Mental health trends

This List covers trend insights about the future of mental health, insights curated between 2018 to 2020, including related topics such as selective traumatic memory erasure, curing PTSD, and addiction.

This List covers trend insights about the future of mental health, insights curated between 2018 to 2020, including related topics such as selective traumatic memory erasure, curing PTSD, and addiction.

Curated by

  • Asimo

Last updated: 24 September 2020

  • | Bookmarked links: 60
Signals
A ‘breakthrough’ depression drug inspired by ketamine is attracting more attention from big pharma
Business Insider
After 35 years of mediocre depression drugs, pharmaceutical companies are jazzed about several new drugs inspired by the club drug ketamine. Allergan, the multinational drugmaker known for Botox, recently dove into research on an injectable depression drug. Now they're going after an oral pill.
Signals
“Magic mushrooms” may be an FDA-approved drug for anxiety and depression in the near future
Vogue
According to a new study, psilocybin found in “magic” mushrooms, could be useful in treating anxiety and depression.
Signals
A search engine for your memories
The Atlantic
An inventor at IBM has patented technology for a cognitive assistant that could learn all about you, then remind you of a name you can't remember the moment you need to say it.
Signals
My adventures with the trip doctors
New York Times
The researchers and renegades bringing psychedelic drugs into the mental health mainstream.
Signals
You can now be diagnosed with burnout
The Cut
The World Health Organization recently included burnout as a diagnosable condition in its manual of diseases/disorders. Burnout typically occurs as a result of overwork, and involves exhaustion and inefficacy at work.
Signals
Psychiatry’s Incurable Hubris
The Atlantic
The biology of mental illness is still a mystery, but practitioners don’t want to admit it.
Signals
How drug companies helped shape a shifting, biological view of mental illness
NPR
Mind Fixers, by historian Anne Harrington, takes a hard look at the ways the marketing of a new pill to treat a mental disorder can change the way the condition is defined and treated.
Signals
Anesthetic drug propofol shows promise in the treatment of medication-resistant depression
PsyPost
A commonly used anesthetic drug could help people with severe depression. Preliminary research published in the International Journal of ...
Signals
A depression drug that's been called 'the most important discovery in half a century' just got a big step closer to FDA approval
Business Insider
Esketamine, a first-of-its-kind depression drug made by Johnson & Johnson, got a big nod on Tuesday from a group of experts convened by regulators.
Signals
Inside the push to legalize magic mushrooms for depression and PTSD
Wired
Activists, entrepreneurs, and doctors in the US and Canada are working to decriminalize psilocybin psychotherapy and calling for a psychedelic revolution.
Signals
Could psychedelic drugs treat PTSD and depression? A Q&A with Rick Doblin
TED
For decades, research into drugs like LSD, MDMA and psilocybin was banned. Now it's time to shed our old fears and fully investigate their potential for treatments that could benefit people with PTSD, depression, substance abuse, and more, says psychedelics expert Rick Doblin.
Signals
Psychedelic medicine is coming. The law isn’t ready
Scientific American
A surprising resurgence of psychedelic research has produced its first FDA-approved treatment, with more likely on the way
Signals
Brain molecule identified as key in anxiety model
UC Davis
Boosting a single molecule in the brain can change “dispositional anxiety,” the tendency to perceive many situations as threatening, in nonhuman primates, researchers from the University of California, Davis, and the University of Wisconsin-Madison have found. The molecule, neurotrophin-3, stimulates neurons to grow and make new connections. The finding provides hope for new
Signals
Are psychiatrists really ready for the AI revolution?
MIT Technology Review
The World Health Organization estimates that up to 15% of the population experiences mental health disorders. That has significant consequences. For example, suicide is the second- or third-leading cause of death for young people in most countries. And as the population ages, the rate of dementia is set to triple over the coming decades. At…
Signals
Tim Ferriss, the man who put his money behind psychedelic medicine
New York Times
The author of “The 4-Hour Workweek” is behind a surge in funding for clinical research into psychedelic drugs.
Signals
Johns Hopkins opening a new psychedelic research center, studying use of ‘magic mushrooms’ and more
The Baltimore Sun
Johns Hopkins Medicine is launching a new psychedelic research center aimed at studying the health and wellness uses of a class of illegal drugs that produce profound changes in consciousness in users.
Signals
Approaching 1,000 mental health startups in 2020
Medium
I nearly died during the summer of 2018 by self-harm, addiction and unmanageable manic episodes. I had reached the end of my rope with addiction, and bipolar disorder. My family found me in a hotel…
Signals
Stanford researchers devise treatment that relieved depression in 90% of participants in small study
Stanford Medicine
Stanford Medicine researchers used high doses of magnetic stimulation, delivered on an accelerated timeline and targeted to individual neurocircuitry, to treat patients with severe depression.